These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31539482)

  • 1. Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection.
    Koepke R; Sill DN; Akhtar WZ; Mitchell KP; Guilfoyle SM; Westergaard RP; Schauer SL; Vergeront JM
    Public Health Rep; 2019; 134(6):651-659. PubMed ID: 31539482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.
    Collier MG; Drobeniuc J; Cuevas-Mota J; Garfein RS; Kamili S; Teshale EH
    Vaccine; 2015 Jun; 33(24):2808-12. PubMed ID: 25889161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
    Harris AM; Millman AJ; Lora M; Osinubi A; Lom J; Miller LS
    Vaccine; 2019 Apr; 37(16):2188-2193. PubMed ID: 30902481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases in Acute Hepatitis B Virus Infections - Kentucky, Tennessee, and West Virginia, 2006-2013.
    Harris AM; Iqbal K; Schillie S; Britton J; Kainer MA; Tressler S; Vellozzi C
    MMWR Morb Mortal Wkly Rep; 2016 Jan; 65(3):47-50. PubMed ID: 26821369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
    BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of hepatitis A in the injecting drug user and homeless populations in Bristol: control by a targeted vaccination programme and possible parenteral transmission.
    Syed NA; Hearing SD; Shaw IS; Probert CS; Brooklyn TN; Caul EO; Barry RE; Sarangi J
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):901-6. PubMed ID: 12867801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
    Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
    MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.
    Yue X; Black CL; O'Halloran A; Lu PJ; Williams WW; Nelson NP
    Vaccine; 2018 Feb; 36(9):1183-1189. PubMed ID: 29395521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?
    Njoroge J; Hope VD; O'Halloran C; Edmundson C; Glass R; Parry JV; Ncube F
    Epidemiol Infect; 2019 Jan; 147():e244. PubMed ID: 31364574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
    Chen H; Cantrell CR
    Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009.
    Lu PJ; Byrd KK; Murphy TV; Weinbaum C
    Vaccine; 2011 Sep; 29(40):7049-57. PubMed ID: 21782873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities.
    Haussig JM; Nielsen S; Gassowski M; Bremer V; Marcus U; Wenz B; Bannert N; Bock CT; Zimmermann R;
    Int J Infect Dis; 2018 Jan; 66():5-13. PubMed ID: 29097248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against hepatitis A and B in persons subject to homelessness in inner Sydney: vaccine acceptance, completion rates and immunogenicity.
    Poulos RG; Ferson MJ; Orr KJ; McCarthy MA; Botham SJ; Stern JM; Lucey A
    Aust N Z J Public Health; 2010 Apr; 34(2):130-5. PubMed ID: 23331355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to Hepatitis A and B Virus Among Clients at a Syringe Services Program in Philadelphia, 2018.
    Figgatt M; Hildick-Smith J; Addish E; Coleman J; Benitez J; Freeland C; Alles S; Viner K; Johnson C; Kuncio D
    Public Health Rep; 2020; 135(5):691-699. PubMed ID: 32791034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.